205 related articles for article (PubMed ID: 23886797)
1. Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer.
Ahn DH; Mehta N; Yorio JT; Xie Y; Yan J; Gerber DE
Clin Lung Cancer; 2013 Nov; 14(6):644-50. PubMed ID: 23886797
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity and stage at diagnosis among lung cancer patients in the US military health system.
Lin J; McGlynn KA; Nations JA; Shriver CD; Zhu K
Cancer Causes Control; 2020 Mar; 31(3):255-261. PubMed ID: 31984449
[TBL] [Abstract][Full Text] [Related]
3. Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer.
Zhao L; Leung LH; Wang J; Li H; Che J; Liu L; Yao X; Cao B
BMC Pulm Med; 2017 Aug; 17(1):112. PubMed ID: 28806935
[TBL] [Abstract][Full Text] [Related]
4. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
Birim O; Kappetein AP; Bogers AJ
Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
[TBL] [Abstract][Full Text] [Related]
5. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
[TBL] [Abstract][Full Text] [Related]
6. Distance from accessible specialist care and other determinants of advanced or unknown stage at diagnosis of people with non-small cell lung cancer: A data linkage study.
Tracey E; McCaughan B; Badgery-Parker T; Young J; Armstrong B
Lung Cancer; 2015 Oct; 90(1):15-21. PubMed ID: 26275475
[TBL] [Abstract][Full Text] [Related]
7. The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection.
Zhai R; Yu X; Shafer A; Wain JC; Christiani DC
Chest; 2014 Feb; 145(2):346-353. PubMed ID: 24008835
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and survival outcome for non-elective referral in non-small cell lung cancer patients--analysis based on the National Lung Cancer Audit.
Beckett P; Tata LJ; Hubbard RB
Lung Cancer; 2014 Mar; 83(3):396-400. PubMed ID: 24457105
[TBL] [Abstract][Full Text] [Related]
9. Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation.
Simon TG; Beland MD; Machan JT; Dipetrillo T; Dupuy DE
Eur J Radiol; 2012 Dec; 81(12):4167-72. PubMed ID: 22835876
[TBL] [Abstract][Full Text] [Related]
10. Prediction of early mortality following stereotactic body radiotherapy for peripheral early-stage lung cancer.
Baker S; Sharma A; Peric R; Heemsbergen WD; Nuyttens JJ
Acta Oncol; 2019 Feb; 58(2):237-242. PubMed ID: 30451552
[TBL] [Abstract][Full Text] [Related]
11. Association between age, deprivation and specific comorbid conditions and the receipt of major surgery in patients with non-small cell lung cancer in England: A population-based study.
Belot A; Fowler H; Njagi EN; Luque-Fernandez MA; Maringe C; Magadi W; Exarchakou A; Quaresma M; Turculet A; Peake MD; Navani N; Rachet B
Thorax; 2019 Jan; 74(1):51-59. PubMed ID: 30100577
[TBL] [Abstract][Full Text] [Related]
12. Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System.
Wainer Z; Wright GM; Gough K; Daniels MG; Russell PA; Choong P; Conron M; Ball D; Solomon B
Clin Lung Cancer; 2018 Nov; 19(6):e933-e944. PubMed ID: 30206043
[TBL] [Abstract][Full Text] [Related]
13. Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer.
Yi YS; Ban WH; Sohng KY
BMC Cancer; 2018 Oct; 18(1):1053. PubMed ID: 30373585
[TBL] [Abstract][Full Text] [Related]
14. Results and impact of routine assessment of comorbidity in elderly patients with non-small-cell lung cancer aged > 80 years.
Breen D; Barlési F; Zemerli M; Doddoli C; Torre JP; Thomas P; Astoul P
Clin Lung Cancer; 2007 Mar; 8(5):331-4. PubMed ID: 17562233
[TBL] [Abstract][Full Text] [Related]
15. Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung Cancer.
Lau SKM; Gannavarapu BS; Carter K; Gao A; Ahn C; Meyer JJ; Sher DJ; Jatoi A; Infante R; Iyengar P
J Oncol Pract; 2018 Apr; 14(4):e211-e220. PubMed ID: 29558251
[TBL] [Abstract][Full Text] [Related]
16. Impact of comorbidity index on morbidity and survival in non-small cell lung cancer.
Otake S; Ohtsuka T; Asakura K; Kamiyama I; Kohno M
Asian Cardiovasc Thorac Ann; 2016 Jan; 24(1):30-3. PubMed ID: 26567555
[TBL] [Abstract][Full Text] [Related]
17. The relationship between chronic obstructive pulmonary disease and non-small cell lung cancer in the elderly.
Wang P; Zhu M; Zhang D; Guo XG; Zhao S; Zhang XL; Wang DL; Liu CT
Cancer Med; 2019 Aug; 8(9):4124-4134. PubMed ID: 31184445
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.
Kocher F; Hilbe W; Seeber A; Pircher A; Schmid T; Greil R; Auberger J; Nevinny-Stickel M; Sterlacci W; Tzankov A; Jamnig H; Kohler K; Zabernigg A; Frötscher J; Oberaigner W; Fiegl M
Lung Cancer; 2015 Feb; 87(2):193-200. PubMed ID: 25564398
[TBL] [Abstract][Full Text] [Related]
19. Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer.
Birim O; Kappetein AP; Goorden T; van Klaveren RJ; Bogers AJ
Ann Thorac Surg; 2005 Sep; 80(3):1021-6. PubMed ID: 16122477
[TBL] [Abstract][Full Text] [Related]
20. Defining the High-Risk Population for Mortality After Resection of Early Stage NSCLC.
Husain ZA; Kim AW; Yu JB; Decker RH; Corso CD
Clin Lung Cancer; 2015 Nov; 16(6):e183-7. PubMed ID: 25979646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]